Consolidated Statements of Mezzanine Equity and Stockholders' Equity - USD ($) $ in Thousands	Total	Redeemable Non-Controlling Interest [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2020	$ 14,179	$ 14,179
Beginning balance at Dec. 31, 2020	1,371,615		$ 0	$ 50	$ 1,501,206	$ (129,370)	$ (271)
Beginning balance, Shares at Dec. 31, 2020			0	504,274,890
Issuance of common stock	1,007				1,007
Issuance of common stock, Shares				110,679
Stock-based compensation expense	254,965				254,965
Stock-based compensation expense, Shares				883,729
Net equity infusion from the Business Combination	704,841			$ 10	704,831
Net equity infusion from the Business Combination, Shares				97,740,002
Exercise of stock options—net of tax	5,180				5,180
Exercise of stock options—net of tax , Shares				1,922,019
Exercise of warrants-Net	60,462			$ 1	60,461
Exercise of warrants-Net, Shares				4,836,977
Accretion of redeemable non-controlling interest	0
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	0
Dividends to CCCIS stockholders	(269,178)					(269,178)
Deemed distribution to CCCIS option holders	(9,006)				(9,006)
Company Vesting Shares granted to CCCIS stockholders					98,885	(98,885)
Foreign currency translation adjustment	(44)						(44)
Net (loss) income	(248,919)					(248,919)
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2021	14,179	14,179
Ending balance at Dec. 31, 2021	1,872,318		$ 0	$ 61	2,618,924	(746,352)	(315)
Ending balance, Shares at Dec. 31, 2021			0	609,768,296
Tax effect of Business Combination transaction costs	1,395				1,395
Stock-based compensation expense	109,387				109,387
Exercise of stock options—net of tax	27,563			$ 1	27,562
Exercise of stock options—net of tax , Shares				10,074,354
Exercise of warrants-Net, Shares				1,246
Issuance of common stock under employee stock purchase plan	3,197				3,197
Issuance of common stock under employee stock purchase plan, Shares				408,879
Issuance of common stock upon vesting of RSUs-net of tax	(5,015)				(5,015)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				1,820,130
Accretion of redeemable non-controlling interest	0
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	0
Foreign currency translation adjustment	(569)						(569)
Net (loss) income	38,406					38,406
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2022	14,179	14,179
Ending balance at Dec. 31, 2022	2,045,287		$ 0	$ 62	2,754,055	(707,946)	(884)
Ending balance, Shares at Dec. 31, 2022			0	622,072,905
Stock-based compensation expense	144,628				144,628
Exercise of stock options—net of tax	25,434			$ 1	25,433
Exercise of stock options—net of tax , Shares				8,923,718
Issuance of common stock under employee stock purchase plan	4,761				4,761
Issuance of common stock under employee stock purchase plan, Shares				641,691
Issuance of common stock upon vesting of RSUs-net of tax	(16,715)				(16,715)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				3,990,467
Repurchase and retirement of common stock	(328,453)			$ (3)		(328,450)
Repurchase and retirement of common stock, Shares				(32,500,000)
Accretion of redeemable non-controlling interest	2,405	2,405
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	(2,405)				(2,405)
Foreign currency translation adjustment	(189)						(189)
Net (loss) income	(90,071)					(90,071)
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2023	16,584	$ 16,584
Ending balance at Dec. 31, 2023	$ 1,782,277			$ 60	$ 2,909,757	$ (1,126,467)	$ (1,073)
Ending balance, Shares at Dec. 31, 2023				603,128,781